<DOC>
	<DOCNO>NCT00552110</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy combination mometasone furoate nasal spray ( MFNS ) oxymetazoline nasal spray ( OXY ) give together day treat subject seasonal allergic rhinitis ( SAR ) relieve symptom include nasal congestion . The secondary objective study evaluate potential combination produce tachyphylaxis and/or rebound congestion , evaluate safety combination .</brief_summary>
	<brief_title>Study Mometasone Furoate Nasal Spray Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis ( P04500 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<criteria>Must 12 year age old , either sex , race . Must least 2year documented history SAR exacerbate time period subject participating . Must document ( within past 12 month ) positive skinprick test response appropriate seasonal allergen appropriate geographical vicinity study carry period time subject participate . Must clinically symptomatic Screening Baseline Visits . Must general good health confirm routine clinical laboratory test electrocardiogram result . Must free clinically significant disease , SAR , would interfere study evaluation . Must willing give write informed consent must able adhere dose visit schedule study requirement . Female subject childbearing potential must negative serum pregnancy test screening . Nonsterile premenopausal female subject must use medically acceptable method birth control prior screen entire study . Must ability transmit electronic diary data regular basis . A subject history anaphylaxis and/or severe local reaction ( ) skin test . A subject asthma require chronic use inhale systemic corticosteroid . A subject current history frequent , clinically significant sinusitis chronic purulent postnasal drip . A subject rhinitis medicamentosa . A subject glaucoma and/or increase intraocular pressure . A subject nasal structural abnormality , include large nasal polyp mark septal deviation , significantly interfere nasal air flow . A subject , opinion investigator , dependent nasal , oral , ocular decongestant , nasal topical antihistamine , nasal steroid . A pregnant nursing female . A subject current evidence clinically significant hematopoietic , cardiovascular , hepatic , renal , neurologic , psychiatric , pulmonary , autoimmune disease , disease precludes subject 's participation study . Particular attention give exclude subject condition would currently interfere absorption , distribution , metabolism , excretion study drug interfere subject 's ability complete reliably complete diary .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>